Phase II Trial of Carboplatin, Paclitaxel, Cetuximab and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer: SWOG S0536

INTRODUCTION: Cetuximab and bevacizumab have each been demonstrated to prolong survival when added to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). However, the potential benefit of combining cetuximab and bevacizumab together with a platinum-based doublet had not been e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Edward S., Moon, James, Herbst, Roy S., Redman, Mary W., Dakhil, Shaker R., Velasco, Mario R., Hirsch, Fred R., Mack, Philip C., Kelly, Karen, Heymach, John V., Gandara, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4072123/
https://ncbi.nlm.nih.gov/pubmed/24189513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados